Nisa Investment Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

Nisa Investment Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$98.1K	Buy	838 +361	+76%	+$36.2K	﹤0.01%	1563
2026 Q1	$44.1K	Hold	477	–	–	﹤0.01%	1715
2025 Q4	$37.7K	Buy	477 +9	+2%	+$646	﹤0.01%	1711
2025 Q3	$34.3K	Hold	468	–	–	﹤0.01%	1753
2025 Q2	$23.8K	Sell	468 -54	-10%	-$2.4K	﹤0.01%	1857
2025 Q1	$23.5K	Hold	522	–	–	﹤0.01%	1816
2024 Q4	$21.6K	Buy	522 +51	+11%	+$2.13K	﹤0.01%	1917
2024 Q3	$18.4K	Buy	471 +112	+31%	+$4.47K	﹤0.01%	1934
2024 Q2	$12.3K	Buy	359 +305	+565%	+$8K	﹤0.01%	2084
2024 Q1	$1.36K	Buy	54 +31	+135%	+$852	﹤0.01%	2307
2023 Q4	$679	Hold	23	–	–	﹤0.01%	2344
2023 Q3	$727	Hold	23	–	–	﹤0.01%	2456
2023 Q2	$595	Hold	23	–	–	﹤0.01%	2528
2023 Q1	$1K	Hold	23	–	–	﹤0.01%	2419
2022 Q4	$0	Buy	+23	New	+$455	﹤0.01%	2657

Other funds holding MIRM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Nisa Investment Advisors's MIRM Position: Q2 2026 in Review

Nisa Investment Advisors increased its Mirum Pharmaceuticals (MIRM) stake by 76% in Q2 2026, buying an estimated $36.2K and bringing the position to 838 shares worth $98.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1563.

Nisa Investment Advisors first reported a position in MIRM in Q4 2022 and has held it in 15 quarters since. 122 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Nisa Investment Advisors held 838 shares of Mirum Pharmaceuticals worth $98.1K as of Q2 2026.
Nisa Investment Advisors bought 361 Mirum Pharmaceuticals shares in Q2 2026, an estimated $36.2K.
Mirum Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1563 holding.
Nisa Investment Advisors first reported a position in Mirum Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
122 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.